| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |